Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells

Neuroscience

Volumn 108, Issue 4, 2001, Pages 701-712

  Mack, T G A ^a,c   Dayanandan, R ^a   Van Slegtenhorst, M ^b   Whone, A ^a   Hutton, M ^b   Lovestone, S ^a   Anderton, B H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MAYO GRADUATE SCHOOL   (United States)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Alzheimer's disease; Frontotemporal dementia and Parkinsonism linked to chromosome 17; Neurodegeneration; Tau mutation; Tau phosphorylation; Tauopathy

Indexed keywords

DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; FTDP 17 PROTEIN; FTDP-17 PROTEIN; GREEN FLUORESCENT PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEINS; PHOTOPROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CHEMISTRY; CHROMOSOME 17; DEMENTIA; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; HUMAN; ISOMERISM; METABOLISM; MICROTUBULE; MUTATION; NERVE CELL; NERVE DEGENERATION; NEUROBLASTOMA; PARKINSON DISEASE; PHOSPHORYLATION; PHYSIOLOGY;

ALZHEIMER DISEASE; CELL DIFFERENTIATION; CHROMOSOMES, HUMAN, PAIR 17; DEMENTIA; GENE EXPRESSION; HUMAN; INDICATORS AND REAGENTS; ISOMERISM; LUMINESCENT PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; MUTATION; NERVE DEGENERATION; NEUROBLASTOMA; NEURONS; PARKINSON DISEASE; PHOSPHORYLATION; SUPPORT, NON-U.S. GOV'T; TAU PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035232501     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00434-1     Document Type: Article

References (39)

1. Arawaka, S., Usami, M., Sahara, N., Schellenberg, G.D., Lee, G., Mori, H., 1999. The tau mutation (val337met) disrupts cytoskeletal networks of microtubules. NeuroReport 10, 993-997.
2. Arrasate, M., Perez, M., Armas-Portela, R., Avila, J., 1999. Polymerization of tau peptides into fibrillar structures. The effect of FTDP-17 mutations. FEBS Lett. 446, 199-202.
3. Braak, E., Braak, H., Mandelkow, E.M., 1994. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol. 87, 554-567.
4. Bramblett, G.T., Trojanowski, J.Q., Lee, V.M., 1992. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins). Lab. Invest. 66, 212-222.
5. Buee, L., Delacourte, A., 1999. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol. 9, 681-693.
6. Dayanandan, R., Van Slegtenhorst, M., Mack, T.G., Ko, L., Yen, S.H., Leroy, K., Brion, J.P., Anderton, B.H., Hutton, M., Lovestone, S., 1999. Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation. FEBS Lett. 446, 228-232.
7. DeTure, M., Ko, L., Yen, S., Nacharaju, P., Easson, C., Lewis, J., Van Slegtenhorst, M., Hutton, M., 2000. Missense tau mutations identified in FTDP-17 have a small effect on tau-microtubule interactions. Brain Res. 853, 5-14.
8. D'Souza, I., Poorkaj, P., Hong, M., Nochlin, D., Lee, V.M., Bird, T.D., Schellenberg, G.D., 1999. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc. Natl. Acad. Sci. USA 96, 5598-5603.
9. Frappier, T., Liang, N.S., Brown, K., Leung, C.L., Lynch, T., Liem, R.K., Shelanski, M.L., 1999. Abnormal microtubule packing in processes of SF9 cells expressing the FTDP-17 V337M tau mutation. FEBS Lett. 455, 262-266.
10. Goedert, M., Jakes, R., Crowther, R.A., 1999. Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments [In Process Citation]. FEBS Lett. 450, 306-311.
11. Goedert, M., Jakes, R., Vanmechelen, E., 1995. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci. Lett. 189, 167-169.
12. Götz, J., Chen, F., Barmettler, R., Nitsch, R.M., 2001. Tau filament formation in transgenic mice expressing P301L tau. J. Biol. Chem. 276, 529-534.
13. Hasegawa, M., Smith, M.J., Goedert, M., 1998. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett. 437, 207-210.
14. Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V., Wszolek, Z., Reed, L., Miller, B.I., Geschwind, D.H., Bird, T.D., McKeel, D., Goate, A., Morris, J.C., Wilhelmsen, K.C., Schellenberg, G.D., Trojanowski, J.Q., Lee, V.M., 1998. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282, 1914-1917.
15. Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., Hackett, J., Adamson, J., Lincoln, S., Dickson, D., Davies, P., Petersen, R.C., Stevens, M., de Graaff, E., Wauters, E., van Baren, J., Hillebrand, M., Joosse, M., Kwon, J.M., Nowotny, P., Heutink, P., 1998. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705.
16. Jalava, A., Akerman, K., Heikkila, J., 1993. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway. J. Cell Physiol. 155, 301-312.
17. Jalava, A., Heikkila, J., Lintunen, M., Akerman, K., Pahlman, S., 1992. Staurosporine induces a neuronal phenotype in SH-SY5Y human neuroblastoma cells that resembles that induced by the phorbol ester 12-O-tetradecanoyl phorbol-13 acetate (TPA). FEBS Lett. 300, 114-118.
18. Lee, D.H., Goldberg, A.L., 1998. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8, 397-403.
19. Lee, G., Rook, S.L., 1992. Expression of tau protein in non-neuronal cells: microtubule binding and stabilization. J. Cell Sci. 102, 227-237.
20. Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Paul Murphy, M., Baker, M., Yu, X., Duff, K., Hardy, J., Corral, A., Lin, W.L., Yen, S.H., Dickson, D.W., Davies, P., Hutton, M., 2000. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nature Genet. 25, 402-405.
21. Lovestone, S., Davis, D.R., Webster, M.T., Kaech, S., Brion, J.P., Matus, A., Anderton, B.H., 1999. Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations [In Process Citation]. Biol. Psychiatry 45, 995-1003.
22. Lovestone, S., Hartley, C.L., Pearce, J., Anderton, B.H., 1996. Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: the effects on the organization and stability of microtubules. Neuroscience 73, 1145-1157.
23. Lovestone, S., Reynolds, C.H., 1997. The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 78, 309-324.
24. Mandelkow, E.M., Mandelkow, E., 1998. Tau in Alzheimer's disease. Trends Cell Biol. 8, 425-427.
25. Matsumura, N., Yamazaki, T., Ihara, Y., 1999. Stable expression in chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) [In Process Citation]. Am. J. Pathol. 154, 1649-1656.
26. Merrick, S.E., Trojanowski, J.Q., Lee, V.M., 1997. Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons. J. Neurosci. 17, 5726-5737.
27. Nacharaju, P., Lewis, J., Easson, C., Yen, S., Hackett, J., Hutton, M., Yen, S.H., 1999. Accelerated filament formation from tau protein with specific FTDP-17 missense mutations. FEBS Lett. 447, 195-199.
28. Nasreddine, Z.S., Loginov, M., Clark, L.N., Lamarche, J., Miller, B.L., Lamontagne, A., Zhukareva, V., Lee, V.M., Wilhelmsen, K.C., Geschwind, D.H., 1999. From genotype to phenotype: a clinical pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation. Ann. Neurol. 45, 704-715.
29. Otvos, L., Jr., Feiner, L., Lang, E., Szendrei, G.I., Goedert, M., Lee, V.M., 1994. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J. Neurosci. Res. 39, 669-673.
30. Perez, M., Lim, F., Arrasate, M., Avila, J., 2000. The FTDP-17-linked mutation R406W abolishes the interaction of phosphorylated tau with microtubules. J. Neurochem. 74, 2583-2589.
31. Poorkaj, P., Bird, T.D., Wijsman, E., Nemens, E., Garruto, R.M., Anderson, L., Andreadis, A., Wiederholt, W.C., Raskind, M., Schellenberg, G.D., 1998. Tau is a candidate gene for chromosome 17 frontotemporal dementia [published erratum appears in Ann. Neurol. 44 (1998) 428]. Ann. Neurol. 43, 815-825.
32. Prince, J.A., Oreland, L., 1997. Staurosporine differentiated human SH-SY5Y neuroblastoma cultures exhibit transient apoptosis and trophic factor independence. Brain Res. Bull. 43, 515-523.
33. Smith, C.J., Anderton, B.H., Davis, D.R., Gallo, J.M., 1995. Tau isoform expression and phosphorylation state during differentiation of cultured neuronal cells. FEBS Lett. 375, 243-248.
34. Sontag, E., Nunbhakdi-Craig, V., Lee, G., Bloom, G.S., Mumby, M.C., 1996. Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A. Neuron 17, 1201-1207.
35. Spillantini, M.G., Goedert, M., 1998. Tau protein pathology in neurodegenerative diseases. Trends Neurosci. 21, 428-433.
36. Spillantini, M.G., Murrell, J.R., Goedert, M., Farlow, M.R., Klug, A., Ghetti, B., 1998. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. USA 95, 7737-7741.
37. Yen, S., Easson, C., Nacharaju, P., Hutton, M., 1999a. FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion. FEBS Lett. 461, 91-95.
38. Yen, S.H., Hutton, M., DeTure, M., Ko, L.W., Nacharaju, P., 1999b. Fibrillogenesis of tau: insights from tau missense mutations in FTDP-17. Brain Pathol. 9, 695-705.
39. Zhong, J., Iqbal, K., Grundke-Iqbal, I., 1999. Hyperphosphorylated tau in SY5Y cells: similarities and dissimilarities to abnormally hyperphosphorylated tau from Alzheimer disease brain. FEBS Lett. 453, 224-228.